주요 내용으로 건너 뛰기
/ 자료 / 컨퍼런스 / Targeted Radiopharmaceuticals Summit

Targeted Radiopharmaceuticals Summit

Targeted Radiopharmaceuticals Summit
We are excited to be presenting at this conference!

Clinical Pharmacology & Model-Informed Drug Development Insights for Targeted Radiation Therapies

Joshua Apgar, PhD

|

VP, Global Head of ABM Scientific Affairs

  • Learn how clinical pharmacology considerations and model-informed drug development (MIDD) concepts help streamline therapeutic index-focused discovery and drug development for TRTs.
  • Learn how to craft strategies that comply with the FDA’s Project Optimus initiative to optimize oncology drug dosage.
  • Understand dose optimization requirements for TRT in the clinical pharmacology regulatory landscape.
  • Discover how MIDD, including quantitative systems pharmacology (QSP) and pharmacometrics, help drive rational drug design, patient selection, and inform dosage optimization.
Powered by Translations.com GlobalLink Web Software